 General Electric Co. won approval from the Food and Drug Administration to offer its 3-D breast-imaging technology in the U.S., the company said, adding substantial new competition to the fast-growing market dominated by Hologic Inc.. Three-dimensional imaging—also known as tomosynthesis—combines X-rays taken from multiple angles to produce a more detailed picture than regular mammograms. The technology costs more than regular mammography, but finds more cancers with fewer false alarms, studies have found, and is rapidly replacing...
  